Volume 6, Issue 12: Future Landscape of CFTR Modulators
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 6, Issue 12)
Target Audience
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Summarize the appropriate use of CFTR modulator therapies in clinical practice, including patient selection, clinical benefits, and ongoing monitoring.
- Explain the potential barriers to the optimal use of CFTR modulators.
- Discuss the role of patient-physician collaboration and communication in the use of CFTR modulator therapies
Claire Wainwright, MBBS, MRCP, FRACP, MD
Professor
University of Queensland
Lady Cilento Children’s Hospital
Brisbane, Australia
Tonia Douglas, FRACP, MD
Senior Clinical Lecturer
University of Queensland
Lady Cilento Children's Hospital
Brisbane, Australia
Available Credit
- 0.50 ANCC
- 0.50 Attendance